Cargando…

Distinct Metalloproteinase Expression and Functions in Systemic Sclerosis and Fibrosis: What We Know and the Potential for Intervention

Systemic sclerosis (SSc) is a chronic debilitating idiopathic disorder, characterized by deposition of excessive extracellular matrix (ECM) proteins such as collagen which leads to fibrosis of the skin and other internal organs. During normal tissue repair and remodeling, the accumulation and turnov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leong, Edwin, Bezuhly, Michael, Marshall, Jean S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432940/ https://www.ncbi.nlm.nih.gov/pubmed/34512395 http://dx.doi.org/10.3389/fphys.2021.727451

Ejemplares similares

Muscle fatigue and muscle weakness: what we know and what we wish we did
por: Karatzaferi, Christina, et al.
Publicado: (2013)

MYBPC1, an Emerging Myopathic Gene: What We Know and What We Need to Learn
por: Geist, Janelle, et al.
Publicado: (2016)

A Systematic Review and Meta-Analysis on Neural Adaptations Following Blood Flow Restriction Training: What We Know and What We Don't Know
por: Centner, Christoph, et al.
Publicado: (2020)

Acute Myocardial Response to Stretch: What We (don't) Know
por: Neves, João S., et al.
Publicado: (2016)

Assembly and Turnover of Caveolae: What Do We Really Know?
por: Han, Bing, et al.
Publicado: (2016)

Commentary: Acute Myocardial Response to Stretch: What We (don't) Know
por: Vahidi, Reza, et al.
Publicado: (2017)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

How scaffolds shape MAPK signaling: what we know and opportunities for systems approaches
por: Witzel, Franziska, et al.
Publicado: (2012)

What do we actually know about exosomal microRNAs in kidney diseases?
por: Li, Qianyu, et al.
Publicado: (2022)

Connexin 43 in Mitochondria: What Do We Really Know About Its Function?
por: Boengler, Kerstin, et al.
Publicado: (2022)

Matrix Metalloproteinases-7 and Kidney Fibrosis
por: Ke, Ben, et al.
Publicado: (2017)

Corrigendum: Matrix Metalloproteinase-7 and Kidney Fibrosis
por: Ke, Ben, et al.
Publicado: (2017)

Editorial: Myocardial fibrosis: What we know now
por: Kania, Gabriela, et al.
Publicado: (2023)

The origin of life: what we know, what we can know and what we will never know
por: Pross, Addy, et al.
Publicado: (2013)

Cutaneous Adnexal Cysts Revisited: What We Know and What We Think We Know
por: Kaya, Gürkan, et al.
Publicado: (2018)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

RNAi Efficiency, Systemic Properties, and Novel Delivery Methods for Pest Insect Control: What We Know So Far
por: Joga, Mallikarjuna R., et al.
Publicado: (2016)

COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
por: Dhawan, Rahul, et al.
Publicado: (2020)

International Trade and Investment and Food Systems: What We Know, What We Don’t Know, and What We Don’t Know We Don’t Know
por: Schram, Ashley, et al.
Publicado: (2020)

Pathological Mechanisms in Diabetes of the Exocrine Pancreas: What’s Known and What’s to Know
por: Wei, Qiong, et al.
Publicado: (2020)

Imprinted Genes and Multiple Sclerosis: What Do We Know?
por: Baulina, Natalia, et al.
Publicado: (2021)

Fibroblast growth factor 21 and dietary interventions: what we know and what we need to know next
por: Jin, Tianru
Publicado: (2022)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Osterholm, Michael T., et al.
Publicado: (2015)

“Tau Oligomers,” What We Know and What We Don’t Know
por: Sahara, Naruhiko, et al.
Publicado: (2014)

Epigenetics in Schistosomes: What We Know and What We Need Know
por: Liu, Weiwei
Publicado: (2016)

Portion Size: What We Know and What We Need to Know
por: Benton, David
Publicado: (2015)

Paediatric schistosomiasis: What we know and what we need to know
por: Osakunor, Derick N. M., et al.
Publicado: (2018)

Immunotherapy and fatigue: what we know and what we don’t know
por: Azeem Khan, Muhammad, et al.
Publicado: (2021)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Metabolic syndrome: what we know and what we need to know
por: Soares, Raquel
Publicado: (2020)

Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
por: Zelek, Wioleta M., et al.
Publicado: (2023)

Commentary: Is this a case in which we know what we don't know what we don't know?
por: Nantsios, Alex, et al.
Publicado: (2021)

Skeletal Muscle Extracellular Matrix – What Do We Know About Its Composition, Regulation, and Physiological Roles? A Narrative Review
por: Csapo, Robert, et al.
Publicado: (2020)

Muscle in Variable Gravity: “I Do Not Know Where I Am, But I Know What to Do”
por: Monti, Elena, et al.
Publicado: (2021)

Nephrotoxicity testing in vitro--what we know and what we need to know.
por: Pfaller, W, et al.
Publicado: (1998)

Asthma in the elderly: what we know and what we have yet to know
por: Yáñez, Anahí, et al.
Publicado: (2014)

What We Know and What We Don't Know About Preventing Stroke
por: Burch, Druin
Publicado: (2014)

Contagious itch: what we know and what we would like to know
por: Schut, C., et al.
Publicado: (2015)

Goal-directed therapy: what we know and what we need to know
por: O’Neal, Jason B, et al.
Publicado: (2015)

Human Extraintestinal Sarcocystosis: What We Know, and What We don’t Know
por: Harris, V. C., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_au0nsi7rfp6madku7svku9uk7f